Publications

Main content

e-citations of ETH:

2017

Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalu1ation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis.
Romana Meletta, Roger Slavik, Linjing Mu, Zoran Rancic, Nicole Borel, Roger Schibli, Simon M. Ametamey, Stefanie D. Krämer, and Adrienne Müller Herde
Nuclear Medicine and Biology, (2017) New York, NY: Elsevier.
GABAA receptor subtypes in the mouse brain: Regional mapping and diazepam receptor occupancy by in vivo [18F]flumazenil PET.
Adrienne Müller Herde, Dietmar Benke, William T. Ralvenius, Linjing Mu, Roger Schibli, Hans U. Zeilhofer, and Stefanie D. Krämer
Neuroimage, (2017) Amsterdam: Elsevier.
CD80 Is Upregulated in a Mouse Model with Shear Stress-Induced Atherosclerosis and Allows for Evaluating CD80-Targeting PET Tracers.
Romana Meletta, Larissa Steier, Nicole Borel, Linjing Mu, Claudia Keller, Aristeidis Chiotellis, Erica Russo, Cornelia Halin, Simon M. Ametamey, Roger Schibli, Stefanie D. Krämer, and Adrienne Müller Herde
Molecular Imaging and Biology, (2017) New York, NY: Springer.

2016

Synthesis and Pharmacological Evaluation of [(11)C]Granisetron and [(18)F]Fluoropalonosetron as PET Probes for 5-HT(3) Receptor Imaging.
Linjing Mu, Adrienne Müller Herde, Pascal M. Rüefli, Filippo Sladojevich, Selena Milicevic Sephton, Stefanie D. Krämer, Andrew J. Thompson, Roger Schibli, Simon M. Ametamey, and Martin Lochner
ACS Chemical Neuroscience, (2016) Washington, DC: American Chemical Society.
Enhanced sensitivity to drugs of abuse and palatable foods following maternal overnutrition.
Daria Peleg-Raibstein, Gitalee Sarker, Kathrin Litwan, Stefanie D. Krämer, Simon M. Ametamey, Roger Schibli, and Christian Wolfrum
Translational Psychiatry, (2016) London: Nature Publishing Group.
Noninvasive PET Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering.
Deana Haralampieva, Thomas Betzel, Ivana Dinulovic, Souzan Salemi, Meline Stoelting, Stefanie D. Krämer, Roger Schibli, Tullio Sulser, Christoph Handschin, Daniel Eberli, and Simon M. Ametamey
The Journal of Nuclear Medicine : JNM, (2016) New York, NY: Society of Nuclear Medicine.
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Roger Slavik, Adrienne Müller Herde, Ahmed Haider, Stefanie D. Krämer, Markus Weber, Roger Schibli, Simon M. Ametamey, and Linjing Mu
Journal of Neurochemistry, (2016) Oxford: Wiley-Blackwell.
Synthesis, Radiolabeling, and Biological Evaluation of 5-Hydroxy-2- F-18 fluoroalkyl-tryptophan Analogues as Potential PET Radiotracers for Tumor Imaging.
Aristeidis Chiotellis, Adrienne Müller Herde, Simon L. Rössler, Ante Brekalo, Erika Gedeonova, Linjing Mu, Claudia Keller, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
Journal of Medicinal Chemistry, (2016) Washington, DC: American Chemical Society.
When barriers ignore the “rule-of-five”.
Stefanie D. Krämer, Hélène E. Aschmann, Maja Hatibovic, Katharina F. Hermann, Claudia S. Neuhaus, Cyrill Brunner, and Sara Belli
Advanced Drug Delivery Reviews, (2016) Amsterdam: Elsevier.
Quantitative aspects of drug permeation across in vitro and in vivo barriers.
Stefanie D. Krämer
European Journal of Pharmaceutical Sciences, (2016) Amsterdam: Elsevier.
Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis.
Romana Meletta, Herde Adrienne Müller, Patrick Dennler, Eliane Fischer, Roger Schibli, and Stefanie D. Krämer
EJNMMI Research, (2016) Berlin: Springer.

2015

Ex vivo differential phase contrast and magnetic resonance imaging for characterization of human carotid atherosclerotic plaques.
Romana Meletta, Nicole Borel, Paul Stolzmann, Alberto Astolfo, Jan Klohs, Marco Stampanoni, Markus Rudin, Roger Schibli, Stefanie D. Krämer, and Adrienne Müller Herde
The International Journal of Cardiovascular Imaging, (2015) Dordrecht: Kluwer Academic.
Quantitative positron emission tomography (PET) of mGluR5 in rat brain with [18F]PSS232 at minimal invasiveness and reduced model complexity.
Adrienne Müller Herde, Claudia Keller, Selena Milicevic Sephton, Linjing Mu, Roger Schibli, Simon M. Ametamey, and Stefanie D. Krämer
Journal of Neurochemistry, (2015) Oxford: Wiley-Blackwell.
Synthesis and pharmacological evaluation of 11C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
Svetlana V. Selivanova, Annamaria Toscano, Carmen Abate, Francesco Berardi, Adrienne Müller, Stefanie D. Krämer, Roger Schibli, and Simon M. Ametamey
Nuclear Medicine and Biology, (2015) New York, NY: Elsevier.
Evaluation of the radiolabeled boronic acid-based FAP Inhibitor MIP-1232 for atherosclerotic plaque imaging.
Romana Meletta, Adrienne Müller Herde, Aristeidis Chiotellis, Isa Malsor, Zoran Rancic, Nicole Borel, Simon M. Ametamey, Stefanie D. Krämer, and Roger Schibli
Molecules, (2015) S.l.: MDPI.
Preclinical imaging of the co-stimulatory ligands CD80/CD86 with 111In-DOTA-Belatacept in oncology and atherosclerosis.
Adrienne Herde, Romana Meletta, P. Dennler, E. Fischer, Roger Schibli, and Stefanie D. Krämer
European Journal of Nuclear Medicine and Molecular Imaging, (2015) Berlin: Springer.
Quantification of Available NMDA (GluN) Receptor NTD Drug Binding Sites with the GluN2B-targeting PET Tracer C-11 NB1.
Stefanie D. Krämer, T. Betzel, L. Mu, B. Tewes, B. Frehland, D. Schepmann, Roger Schibli, B. Wunsch, and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, (2015) Berlin: Springer.
Positron Emission Tomography (PET): Quantification and Kinetic Modeling.
Stefanie D. Krämer
In Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, edited by Jan Reedijk. (2015) Amsterdam: Elsevier.
Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).
Selena Milicevic Sephton, Adrienne Müller Herde, Linjing Mu, Claudia Keller, Sonja Rüdisühli, Yves Auberson, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
European Journal of Nuclear Medicine and Molecular Imaging, (2015) Berlin: Springer.
Discovery of a Fluorinated 4-Oxo-Quinoline Derivative as a Potential PET Radiotracer for Targeting CB2 Receptor.
L. Mu, R. Slavik, A.H. Muller, Stefanie D. Krämer, M. Weber, Roger Schibli, and Simon M. Ametamey
European Journal of Nuclear Medicine and Molecular Imaging, (2015) Berlin: Springer.
Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor.
Roger Slavik, Adrienne Müller Herde, Daniel Bieri, Markus Weber, Roger Schibli, Stefanie D. Krämer, Simon M. Ametamey, and Linjing Mu
European Journal of Medicinal Chemistry, (2015) Paris: Elsevier.
Accurate molecular imaging of small animals taking into account animal models, handling, anaesthesia, quality control and imaging system performance.
Christian Vanhove, Jens P. Bankstahl, Stefanie D. Krämer, Eric Visser, Nicola Belcari, and Stefaan Vandenberghe
EJNMMI Phys, (2015) Heidelberg: Springer.

2014

Cell-Free Microfluidic Determination of P-glycoprotein Interactions with Substrates and Inhibitors.
Klaus Eyer, Michael Herger, Stefanie D. Krämer, and Petra S. Dittrich
Pharmaceutical Research, (2014) Berlin: Springer.
Synthesis and biological evaluation of ((5-hydroxy(2-(3-[18F]fluoropropyl))tryptophan ([18F]5OH-2FPTRP) as a potential PET tumor imaging agent.
A. Chiotellis, A. Müller, L. Mu, S. Rössler, C. Keller, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, (2014) Berlin: Springer.
Radioligand development for imaging cannabinoid receptor subtype 2 with PET.
L. Mu, R. Slavik, A. Muller, M. Weber, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, (2014) Berlin: Springer.
Targeting the Immune Co-Stimulatory Molecule CD80 for the Imaging of Vulnerable Atherosclerotic Plaques by Pet.
R. Meletta, A. Müller, L. Mu, A. Chiotellis, N. Borel, Z. Rancic, P.A. Kaufmann, Simon M. Ametamey, Roger Schibli, and Stefanie D. Krämer
Atherosclerosis, (2014) Amsterdam: Elsevier.
Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
Adrienne Mueller, Stefanie D. Krämer, Romana Meletta, Katharina Beck, Svetlana V. Selivanova, Zoran Rancic, Philipp A. Kaufmann, Bernhard Vos, Jörg Meding, Timo Stellfeld, Tobias K. Heinrich, Marcus Bauser, Joachim Huetter, Ludger M. Dinkelborg, Roger Schibli, and Simon M. Ametamey
Nuclear medicine and biology, (2014) New York, NY: Elsevier.
Towards non-invasive imaging of vulnerable atherosclerotic plaques by targeting co-stimulatory molecules.
Adrienne Müller, Linjing Mu, Romana Meletta, Katharina Beck, Zoran Rancic, Konstantin Drandarov, Philipp A. Kaufmann, Simon M. Ametamey, Roger Schibli, Nicole Borel, and Stefanie D. Krämer
International journal of cardiology, (2014) Amsterdam: Elsevier.
Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition.
Dennis Smith, Per Artursson, Alex Avdeef, Li Di, Gerhard F. Ecker, Bernhard Faller, Brian J. Houston, Manfred Kansy, Edward H. Kerns, Stefanie D. Krämer, Hans Lennernäs, Han van de Waterbeemd, Kiyohiko Sugano, and Bernard Testa
Molecular pharmaceutics, (2014) Washington, DC: American Chemical Society.
Imaging Tumour ATB0,+ Transport Activity by PET with the Cationic Amino Acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine.
Adrienne Müller, Aristeidis Chiotellis, Claudia Keller, Simon M. Ametamey, Roger Schibli, Linjing Mu, and Stefanie D. Krämer
Molecular imaging and biology, (2014) New York: Springer.
MRS glucose mapping and PET joining forces. Re-evaluation of the lumped constant in the rat brain under isoflurane anaesthesia.
Malte F. Alf, João M.N. Duarte, Hongxia Lei, Stefanie D. Krämer, Vladimir Mlynarik, Roger Schibli, and Rolf Gruetter
Journal of Neurochemistry, (2014) Oxford: Wiley-Blackwell.
Development and Evaluation of Novel PET Tracers for Imaging Cannabinoid Receptor Type 2 in Brain.
R. Slavik, D. Bieri, S. Cermak, A. Muller, Stefanie D. Krämer, M. Weber, Roger Schibli, Simon M. Ametamey, and L.J. Mu
Chimia, (2014) Bern: Swiss Chemical Society.
Synthesis and preliminary evaluation of a 2-Oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor.
Linjing Mu, Roger Slavik, Adrienne Müller, Kasim Popaj, Stjepko Čermak, Markus Weber, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
Pharmaceuticals, (2014) Switzerland: MDPI AG.
Imaging Atherosclerotic Plaque Inflammation via Folate Receptor Targeting Using a Novel F-18-Folate Radiotracer.
Adrienne Müller, Katharina Beck, Zoran Rancic, Cristina Müller, Cindy R. Fischer, Thomas Betzel, Philipp A. Kaufmann, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
Molecular Imaging, (2014) Lewiston, NY: BC Decker.
Synthesis and Biological Evaluation of 18F-Labeled Fluoroethoxy Tryptophan Analogues as Potential PET Tumor Imaging Agents.
Aristeidis Chiotellis, Adrienne Müller, Linjing Mu, Claudia Keller, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
Molecular pharmaceutics, (2014) Washington, DC: American Chemical Society.
Synthesis and preliminary biological evaluation of O-2((2-[18F]fluoroethyl)methylamino)ethyltyrosine ([18F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging.
Aristeidis Chiotellis, Adrienne Müller, Karin Weyermann, Dominique S. Leutwiler, Roger Schibli, Simon M. Ametamey, Stefanie D. Krämer, and Lingjing Mu
Amino Acids, (2014) Wien: Springer.
A liposomal fluorescence assay to study permeation kinetics of drug-like weak bases across the lipid bilayer.
K. Eyer, F. Paech, F. Schuler, P. Kuhn, R. Kissner, S. Belli, Petra S. Dittrich, and Stefanie D. Krämer
Journal of Controlled Release, (2014) Amsterdam: Elsevier.

2013

Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ2 receptors.
Carmen Abate, Svetlana V. Selivanova, Adrienne Müller, Stefanie D. Krämer, Roger Schibli, Roberta Marottoli, Roberto Perrone, Francesco Berardi, Mauro Niso, and Simon M. Ametamey
European journal of medicinal chemistry, (2013) Paris: Elsevier.
FEMAET: a Cationic Amino Acid PET Probe Targeting the Concentrative Amino Acid Transporter ATB0,+.
Stefanie D. Krämer, A. Müller, A. Chiotellis, L. Mu, C. Keller, Simon M. Ametamey, and Roger Schibli
European journal of nuclear medicine and molecular imaging, (2013) Berlin: Springer.
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Linjing Mu, Daniel Bieri, Roger Slavik, Konstantin Drandarov, Adrienne Müller, Stjepko Čermak, Markus Weber, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
Journal of neurochemistry, (2013) Oxford: Wiley-Blackwell.
FDG kinetic modeling in small rodent brain PET. Optimization of data acquisition and analysis.
Malte F. Alf, Marianne I. Martić-Kehl, Roger Schibli, and Stefanie D. Krämer
EJNMMI research, (2013) Heidelberg: Springer.
Characterization of Different Osteosarcoma Phenotypes by PET Imaging in Preclinical Animal Models.
Carmen Campanile, Matthias J.E. Arlt, Stefanie D. Krämer, Michael Honer, Ana Gvozdenovic, Patrick Brennecke, Cindy R. Fischer, Adam A. Sabile, Adrienne Müller, Simon M. Ametamey, Walter Born, Roger Schibli, and Bruno Fuchs
The journal of nuclear medicine, (2013) New York: Society of Nuclear Medicine.
Design, Synthesis, and Initial Evaluation of a High Affinity Positron Emission Tomography Probe for Imaging Matrix Metalloproteinases 2 and 9.
Svetlana V. Selivanova, Timo Stellfeld, Tobias K. Heinrich, Adrienne Müller, Stefanie D. Krämer, P. August Schubiger, Roger Schibli, Simon M. Ametamey, Bernhard Vos, Jörg Meding, Marcus Bauser, Joachim Hütter, and Ludger M. Dinkelborg
Journal of medicinal chemistry, (2013) Washington, DC: American Chemical Society.
F-18 -PSS232-A novel PET radiotracer for imaging of metabotropic glutamate receptors subtype 5 (mGluR5).
S. M. Sephton, L. J. Mu, A. Muller, C. Keller, Stefanie D. Krämer, Roger Schibli, and Simon M. Ametamey
Journal of labelled compounds and radiopharmaceuticals, (2013) Hoboken, NJ, USA: Wiley-Blackwell.
Synthesis and in vitro/in vivo pharmacological evaluation of [11C]-ThioABP, a novel radiotracer for imaging mGluR5 with PET.
Selena Sephton, Linjing Mu, Adrienne Müller, Cindy A. Wanger-Baumann, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
Medchemcomm, (2013) Cambridge: Royal Society of Chemistry.
Radiosynthesis and Preclinical Evaluation of 3 '-Aza-2 '- F-18 fluorofolic Acid. A Novel PET Radiotracer for Folate Receptor Targeting.
Thomas Betzel, Cristina Müller, Viola Groehn, Adrienne Müller, Josefine Reber, Cindy R. Fischer, Stefanie D. Krämer, Roger Schibli, and Simon M. Ametamey
Bioconjugate Chemistry, (2013) Washington, DC: American Chemical Society.
Quantification of Brain Glucose Metabolism by F-18-FDG PET with Real-Time Arterial and Image-Derived Input Function in Mice.
Malte F. Alf, Matthias T. Wyss, Alfred Buck, Bruno Weber, Roger Schibli, and Stefanie D. Krämer
Journal of Nuclear Medicine, (2013) New York: Society of Nuclear Medicine.
Synthesis and biological evaluation of 18F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Aristeidis Chiotellis, Linjing Mu, Adrienne Müller, Svetlana V. Selivanova, Claudia Keller, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
European journal of medicinal chemistry, (2013) Paris: Elsevier.
Development of novel cannabinoid type 2 receptor tracers for PET imaging.
Linjing Mu, Roger Slavik, Daniel Bieri, Konstantin Drandarov, Adrienne Muller, Stefanie D. Krämer, Roger Schibli, and Simon M. Ametamey
Journal of labelled compounds and radiopharmaceuticals, (2013) Hoboken, NJ, USA: Wiley-Blackwell.
Synthesis and preclinical evaluation of a new C-6 alkylated pyrimidine derivative as a PET Imaging agent for HSV1-tk gene Expression.
Ursina Müller, Tobias L. Ross, Charlene Ranadheera, Roger Slavik, Adrienne Müller, Mariana Born, Evelyn Trauffer, Selena Milicevic Sephton, Leonardo Scapozza, Stefanie D. Krämer, and Simon M. Ametamey
American journal of nuclear medicine and molecular imaging, (2013) Madison, Wis.: e-Century Publ..

2012

Evaluation of fluorescence anisotropy to assess drug–lipid membrane partitioning.
Juan M. Pallicer, and Stefanie D. Krämer
Journal of pharmaceutical and biomedical analysis, (2012) Amsterdam: Elsevier.
Comparison of two F-18-labeled folate PET tracers, following the integrated approach.
T. Betzel, C. Müller, V. Gröhn, A. Müller, J. Reber, Stefanie D. Krämer, Roger Schibli, and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, (2012) New York, NY, USA: Springer.
Synthesis, radiolabelling and in vitro/in vivo evaluation of a novel PET ligand for imaging of metabotropic glutamate receptor subtype 5.
L. Mu, S.M. Sephton, A. Müller, C.A. Wanger-Baumann, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
European journal of nuclear medicine and molecular imaging, (2012) New York, NY, USA: Springer.
Expression Profiles of Metabolic Enzymes and Drug Transporters in the Liver and along the Intestine of Beagle Dogs.
Stephanie Haller, Franz Schuler, Stanley E. Lazic, Dalila Bachir-Cherif, Stefanie D. Krämer, Neil J. Parrott, Guido Steiner, and Sara Belli
Drug Metabolism and Disposition, (2012) Bethesda, Md.: ASPET.
Synthesis and evaluation of novel alpha-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers.
Selena Milicevic Sephton, Linjing Mu, W. Bernd Schweizer, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
Journal of medicinal chemistry, (2012) Washington, DC: American Chemical Society.
Synthesis and Evaluation of Novel α-Fluorinated (E)-3-((6-Methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl Oxime (ABP688) Derivatives as Metabotropic Glutamate Receptor Subtype 5 PET Radiotracers.
Selena Milicevic Sephton, Linjing Mu, W. Bernd Schweizer, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
Journal of medicinal chemistry, (2012) Washington, DC: American Chemical Society.
Radiofluorinated histamine H-3 receptor antagonist as a potential probe for in vivo PET imaging. Radiosynthesis and pharmacological evaluation.
Svetlana V. Selivanova, Michael Honer, Francine Combe, Kathleen Isensee, Holger Stark, Stefanie D. Krämer, P. August Schubiger, and Simon M. Ametamey
Bioorganic & medicinal chemistry, (2012) Amsterdam: Elsevier.
[18F]Fluoro-Deoxy-Glucose Folate: A Novel PET Radiotracer with Improved in Vivo Properties for Folate Receptor Targeting.
Cindy R. Fischer, Cristina Müller, Josefine Reber, Adrienne Muller, Stefanie D. Krämer, Simon M. Ametamey, and Roger Schibli
Bioconjugate Chemistry, (2012) Washington, D.C.: American Chemical Society.
Synthesis and evaluation of a C-6 alkylated pyrimidine derivative for the in vivo imaging of HSV1-TK gene expression.
Ursina Müller, Miljen Martic, Tatjana Gazivoda Kraljevic, Svjetlana Kristafor, Tobias L. Ross, Charlene Ranadheera, Adrienne Müller, Mariana Born, Stefanie D. Krämer, Silvana Raic-Malic, and Simon M. Ametamey
Nuclear Medicine and Biology, (2012) New York: Elsevier.
Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5.
Selena Milicevic Sephton, Patrick Dennler, Dominique S. Leutwiler, Linjing Mu, Cindy A. Wanger-Baumann, Roger Schibli, Stefanie D. Krämer, and Simon M. Ametamey
American journal of nuclear medicine and molecular imaging, (2012) Madison, Wis.: e-Century Publ..

2011

Anti-VEGF antibody treatment accelerates polycystic kidney disease.
Shagun Raina, Michael Honer, Stefanie D. Krämer, Yang Liu, Xueqi Wang, Stephan Segerer, Rudolf P. Wuthrich, and Andreas L. Serra
American journal of physiology, (2011) Boston: American Physiological Society.
(18)F-Labeling, in vitro and in vivo studies of a bombesin analogue for the imaging of GRP receptor-positive prostate cancer.
L.O. Dialer, S.V. Selivanova, Stefanie D. Krämer, A. Muller, Roger Schibli, Simon M. Ametamey, T. Stellfeld, K. Graham, S. Borkowski, L.M. Dinkelborg, and A. Srinivasan
Journal of labelled compounds and radiopharmaceuticals, (2011) Chichester, UK: Wiley.
Radiosynthesis, in vitro and in vivo characterization of O-(2- (18)F fluoroethyl)-5-hydroxy-L-tryptophan.
L. Mu, O. Kuznetsova, C. Schweinsberg, A. Muller, C. Muller, T. Ross, D. Franck, Roger Schibli, and Stefanie D. Krämer
Journal of labelled compounds and radiopharmaceuticals, (2011) Chichester: Wiley.
In vitro and in vivo evaluation of [F-18]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
Cindy A. Wanger-Baumann, Linjing Mu, Michael Honer, Sara Belli, Malte F. Alf, Pius A. Schubiger, Stefanie D. Krämer, and Simon M. Ametamey
NeuroImage, (2011) Amsterdam: Elsevier.
Development of A [F-18]-labelled analogue of [C-11]-ABP688 for the pet imaging of the metabotropic glutamate receptor subtype 5 (MGLUR5).
C.A. Baumann, L. Mu, M. Honer, Stefanie D. Krämer, P.A. Schubiger, and Simon M. Ametamey
Journal of labelled compounds and radiopharmaceuticals, (2011) Chichester: Wiley.
Muscle precursor cells are safe for the treatment of urinary incontinence after surgery for prostate cancer.
M.N.L. Stölting, Stefanie D. Krämer, Simon M. Ametamey, S. Ferrari, A. Becskei, T. Sulser, and D. Eberli
European urology. Supplements, (2011) Amsterdam: Elsevier Science.
Pharmacokinetics and safety of panobacumab. Specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.
Qin Lu, Jean-Jacques Rouby, Pierre-Francois Laterre, Philippe Eggimann, Anthony Dugard, Evangelos J. Giamarellos-Bourboulis, Emanuelle Mercier, Jorge Garbino, Charles-Edouard Luyt, Jean Chastre, Violetta Georgescu-Kyburz, Michael P. Rudolf, Verena Gafner, Hedvika Lazar, Holger Koch, Antonio Perez, Stefanie D. Krämer, and Michael Tamm
The journal of antimicrobial chemotherapy, (2011) Oxford, UK: Oxford University Press.

2010

Particle size and activation threshold. A new dimension of danger signaling.
Lorna Rettig, Sebastian P. Haen, Anne Greet Bittermann, Lotta von Böhmer, Alessandra Curioni, Stefanie D. Krämer, Alexander Knuth, and Steve Pascolo
Blood, (2010) Washington, DC: American Society of Hematology.
Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands.
Cindy A. Baumann, Linjing Mu, Nicole Wertli, Stefanie D. Krämer, Michael Honer, Pius A. Schubiger, and Simon M. Ametamey
Bioorganic & medicinal chemistry, (2010) Amsterdam: Elsevier.
The biochemistry of drug metabolism. 2, Conjugations, consequences of metabolism, influencing factors.
Bernard Testa, and Stefanie D. Krämer
(2010) Zürich: Helvetica Chimica Acta Wiley-VCH.

2009

Lipid membrane interactions of indacaterol and salmeterol. Do they influence their pharmacological properties?
Dario Lombardi, Bernard Cuenoud, and Stefanie D. Krämer
European journal of pharmaceutical sciences, (2009) Amsterdam: Elsevier.
Why and how pharmacokinetics change from birth to adolescence. An introduction.
Stefanie D. Krämer
Bulletin technique Gattefossé, (2009) Saint-Priest: Gattefossé.
Lipid-bilayer permeation of drug-like compounds.
Stefanie D. Krämer, Dario Lombardi, Adriana Primorac, Anita V. Thomae, and Heidi Wunderli-Allenspach
Chemistry & biodiversity, (2009) Zürich: Verlag Helvetica Chimica Acta.
Cholesterol-mediated activation of P-glycoprotein. Distinct effects on basal and drug-induced ATPase activities.
Sara Belli, Priska M. Elsener, Heidi Wunderli-Allenspach, and Stefanie D. Krämer
Journal of pharmaceutical sciences, (2009) New York: Wiley.
The Biochemistry of Drug Metabolism - An Introduction. Part 7. Intra-Individual Factors Affecting Drug Metabolism.
Stefanie D. Krämer, and Bernard Testa
Chemistry & Biodiversity, (2009) Zürich: Verlag Helvetica Chimica Acta.
Interaction kinetics of salmeterol with egg phosphatidylcholine liposomes by surface plasmon resonance.
Dario Lombardi, Bernard Cuenoud, Heidi Wunderli-Allenspach, and Stefanie D. Krämer
Analytical biochemistry : methods in the biological sciences, (2009) San Diego: Elsevier.
Suitability of Endothelin Receptor Subtype A as a Target for PET Imaging of Atherosclerotic Plaques.
T.L. Ross, M. Honer, S. Belli, Stefanie D. Krämer, J. Kelm, S.P. Hoerstrup, P. Kaufmann, A.P. Schubiger, and Simon M. Ametamey
Journal of labelled compounds and radiopharmaceuticals, (2009) Chichester: Wiley.
The Biochemistry of Drug Metabolism. An Introduction. Part 5. Metabolism and Bioactivity.
Bernard Testa, and Stefanie D. Krämer
Chemistry & biodiversity, (2009) Zürich: Wiley.

2008

Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis.
G. di Maira, F. Brustolon, K. Tosoni, S. Belli, Stefanie D. Krämer, L. A. Pinna, and M. Ruzzene
Molecular and cellular biochemistry, (2008) Berlin: Springer.
Dynamics and Cleavability at the α-Cleavage Site of APP(684-726) in Different Lipid Environments.
Marco Marenchino, Philip T.F. Williamson, Samuel Murri, Giorgia Zandomeneghi, Heidi Wunderli-Allenspach, Beat H. Meier, and Stefanie D. Krämer
Biophysical journal, (2008) Bethesda, MD: Biophysical Society.
The biochemistry of drug metabolism. An introduction: Part 6. Inter-individual factors affecting drug metabolism.
Stefanie D. Krämer, and B. Testa
Chemistry & biodiversity, (2008) Zürich: Wiley.
The Biochemistry of Drug Metabolism - An Introduction. Part 6. Inter-Individual Factors Affecting Drug Metabolism.
Stefanie D. Krämer, and Bernard Testa
Chemistry & biodiversity, (2008) Zürich: Verlag Helvetica Chimica Acta.
Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis.
Giovanni Di Maira, Francesca Brustolon, Kendra Tosoni, Sara Belli, Stefanie D. Krämer, Lorenzo A. Pinna, and Maria Ruzzene
Molecular and Cellular Biochemistry, (2008) Berlin: Springer.
The biochemistry of drug metabolism. An introduction: part 4. reactions of conjugation and their enzymes.
Bernard Testa, and Stefanie D. Krämer
Chemistry & biodiversity : an official journal of the Center for the Study of Biological Complexity (CSBC), Virgina Commonwealth University, USA, (2008) Zürich: Verlag Helvetica Chimica Acta.
The biochemistry of drug metabolism. 1, Principles, redox reactions, hydrolyses.
Bernard Testa, and Stefanie D. Krämer
(2008) Zürich: Helvetica Chimica Acta Wiley-VCH.

2007

P-Glycoprotein in proteoliposomes with low residual detergent. The effects of cholesterol.
Karsten Bucher, Sara Belli, Heidi Wunderli-Allenspach, and Stefanie D. Krämer
Pharmaceutical research, (2007) Berlin: Springer.
Kinetic study of drug/lipid membrane interactions with surface plasmon resonance (SPR).
Dario Lombardi, Bernard Cuenoud, and Stefanie D. Krämer
Biophysical journal, (2007) Cambridge, MA: Cell Press ; Elsevier.
Permeation of a β-heptapeptide derivative across phospholipid bilayers.
Toshinori Shimanouchi, Peter Walde, James Gardiner, Yogesh R. Mahajan, Dieter Seebach, Anita Thomae, Stefanie D. Krämer, Matthias Voser, and Ryoichi Kuboi
Biochimica et biophysica acta, (2007) Amsterdam: Elsevier.
The biochemistry of drug metabolism - An introduction Part 3. Reactions of hydrolysis and their enzymes.
B. Testa, and Stefanie D. Krämer
Chemistry & biodiversity, (2007).
The biochemistry of drug metabolism. An introduction - Part 2. Redox reactions and their enzymes.
Bernard Testa, and Stefanie D. Krämer
Chemistry & biodiversity, (2007) Zürich: Verlag Helvetica Chimica Acta.
The biochemistry of drug metabolism - An introduction. Part 3. Reactions of hydrolysis and their enzymes.
Bernard Testa, and Stefanie D. Krämer
Chemistry & Biodiversity, (2007) Zürich: Verlag Helvetica Chimica Acta.
Comparing the lipid membrane affinity and permeation of drug-like acids. The intriguing effects of cholesterol and charged lipids.
A.V. Thomae, T. Koch, C. Panse, H. Wunderli-Allenspach, and Stefanie D. Krämer
Pharmaceutical research, (2007) Berlin: Springer.
Comparing the lipid membrane affinity and permeation of drug-like acids. The intriguing effects of cholesterol and charged lipids.
Anita V. Thomae, Tamara Koch, Christian Panse, Heidi Wunderli-Allenspach, and Stefanie D. Krämer
Pharmaceutical research, (2007) Berlin: Springer.
The obstacle course of drugs in the body. Predictive tools for the in vivo barrier crossing of drugs.
H. Wunderli-Allenspach, and Stefanie D. Krämer
BioForum Europe, (2007) Darmstadt: GIT Verlag.

2006

Role of drug efflux carriers in the healthy and diseased brain.
Dirk M. Hermann, Ertugrul Kilic, Annett Spudich, Stefanie D. Krämer, Heidi Wunderli-Allenspach, and Claudio L. Bassetti
Annals of neurology, (2006) New York, NY: Wiley-Blackwell.
Comparison of permeation through phosphatidylcholine bilayers of N-dipicolinyl-alpha- and -beta-oligopeptides.
James Gardiner, Anita V. Thomae, Raveendra I. Mathad, Dieter Seebach, and Stefanie D. Krämer
Chemistry & biodiversity, (2006) Zürich: Verlag Helvetica Chimica Acta.
Lipid bilayer in ADME. Permeation barriers and distribution compartments.
Stefanie D. Krämer
In Pharmacokinetic profiling in drug research : biological, physicochemical, and computational strategies, edited by Bernard Testa, Stefanie D. Krämer and Heidi Wunderli-Allenspach, 203-220. (2006) Zürich: Verlag Helvetica Chimica Acta.
Lipid bilayers in ADME. Permeation barriers and distribution compartments.
Stefanie D. Krämer
In Pharmacokinetic profiling in drug research : biological, physicochemical, and computational strategies, edited by Bernard Testa, Stefanie D. Krämer and Heidi Wunderli-Allenspach, 203-220. (2006) Zürich: Verlag Helvetica Chimica Acta.
The biochemistry of drug metabolism. An introduction - Part 1. Principles and overview.
Bernard Testa, and Stefanie D. Krämer
Chemistry & biodiversity, (2006) Zürich: Verlag Helvetica Chimica Acta.

2005

Permeation of Aromatic Carboxylic Acids across Lipid Bilayers. The pH-Partition Hypothesis Revisited.
Anita V. Thomae, Heidi Wunderli-Allenspach, and Stefanie D. Krämer
Biophysical journal, (2005) Cambridge, MA: Elsevier.
Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells.
Sarah W. Kamau, Stefanie D. Krämer, Maja Günthert, and Heidi Wunderli-Allenspach
In vitro cellular & developmental biology. Animal, (2005) Heidelberg: Springer.
Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities.
Carsten Bucher, Camille A. Besse, Sarah W. Kamau, Heidi Wunderli-Allenspach, and Stefanie D. Krämer
Pharmaceutical research, (2005) Berlin: Springer.
Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P Glycoprotein-related activities.
Karsten Bucher, Camille A. Besse, Sarah W. Kamau, Heidi Wunderli-Allenspach, and Stefanie D. Krämer
Pharmaceutical research, (2005) Berlin: Springer.
Lipid bilayers in ADME. permeation barriers and distribution compartments.
Stefanie D. Krämer
In Pharmacokinetic Profiling in Drug Research, edited by Bernard Testa, Stefanie D. Krämer, Heidi Wunderli-Allenspach and Gerd Folkers. (2005) Zürich: Wiley, Verlag Helvetica Chimica Acta.

2004

Exploring barrier mechanisms relevant for drug therapy.
Heidi Wunderli-Allenspach, Karsten Bucher, Jiri Hofmann, Marco Marenchino, Anita Thomae, Maja Günthert, and Stefanie D. Krämer
Chimia, (2004) Bern: Swiss Chemical Society.
α-Tocopherol influences the lipid membrane affinity of desipramine in a pH-dependent manner.
Marco Marenchino, Andrea L. Alpstäg-Wöhrle, Barbara Christen, Heidi Wunderli-Allenspach, and Stefanie D. Krämer
European journal of pharmaceutical sciences, (2004) Amsterdam: Elsevier.

2003

No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides.
Stefanie D. Krämer, and H. Wunderli-Allenspach
Biochimica et biophysica acta, (2003) Amsterdam: Elsevier.

2002

Lipids in blood-brain barrier models in vitro I: Thin-layer chromatography and high-performance liquid chromatography for the analysis of lipid classes and long-chain polyunsaturated fatty acids.
Stefanie D. Krämer, Johannah A. Hurley, N. Joan Abbott, and David J. Begley
In vitro cellular & developmental biology. Animal, (2002) Heidelberg: Springer.
Lipids in blood-brain barrier models in vitro II. Influence of glial cells on lipid classes and lipid fatty acids.
Stefanie D. Krämer, Yanic B. Schütz, Heidi Wunderli-Allenspach, N. Joan Abbott, and David J. Begley
In Vitro Cellular & Developmental Biology. Animal, (2002) Heidelberg: Springer.

2001

Physicochemical properties in pharmacokinetic lead optimization.
Stefanie D. Krämer, and Heidi Wunderli-Allenspach
Il Farmaco, (2001) New York, NY: Elsevier Science.
Biological models to study blood-brain barrier permeation.
Stefanie D. Krämer, N. Joan Abbott, and David J. Begley
In Pharmacokinetic optimization in drug research : biological, physicochemical, and computational strategies, edited by Bernard Testa, Han van de Waterbeemd, Gerd Folkers and Richard Guy, 127-154. (2001) Zürich: Verlag Helvetica Chimica Acta.
Liposome/Water Partitioning. Theory, Techniques, and Applications.
Stefanie D. Krämer
In Pharmacokinetic optimization in drug research, edited by Bernard Testa, Han van de Waterbeemd, Gerd Folkers and Richard Guy, 401. (2001) Zürich: Verlag Helvetica Chimica Acta, 2001.

2000

P-Glycoprotein in cell cultures. A combined approach to study expression, localisation, and functionality in the confocal microscope.
Sibylle P. Hämmerle, Barbara Rothen-Rutishauser, Stefanie D. Krämer, Maja M. Günthert, and Heidi Wunderli-Allenspach
European journal of pharmaceutical sciences, (2000) Amsterdam: Elsevier.
Cell cultures as tools in biopharmacy.
Annette Braun, Sibylle Hämmerle, Kayoshi Suda, Barbara Rothen-Rutishauser, Maja M. Günthert, Stefanie D. Krämer, and Heidi Wunderli-Allenspach
European journal of pharmaceutical sciences, (2000) Amsterdam: Elsevier.
Permeation Studies In Vitro and In Vivo of Potential Radiopharmaceuticals with Affinity to Neuro Receptors.
Matthias Friebe, Kayoshi Suda, Hartmut Spies, Rosmarie Syhre, Ralf Berger, Bernd Johannsen, Efstratios Chiotellis, Stefanie D. Krämer, and Heidi Wunderli-Allenspach
Pharmaceutical research, (2000) Berlin: Springer.

1999

Absorption prediction from physicochemical parameters.
Stefanie D. Krämer
Pharmaceutical science & technology today, (1999) Kidlington: Elsevier Science.

1998

MDCK Cell Cultures as an Epithelial In Vitro Model. Cytoskeleton and Tight Junctions as Indicators for the Definition of Age-Related Stages by Confocal Microscopy.
Barbara Rothen-Rutishauser, Stefanie D. Krämer, Annette Braun, Maja M. Günthert, and Heidi Wunderli-Allenspach
Pharmaceutical research, (1998) Berlin: Springer.
Towards the Predictability of Drug-Lipid Membrane Interactions. The pH-Dependent Affinity of Propranolol to Phosphatidylinositol Containing Liposomes.
Stefanie D. Krämer, Annette Braun, Christina Jakits-Deiser, and Heidi Wunderli-Allenspach
Pharmaceutical research, (1998) Berlin: Springer.
Considerations on the potentiometric log P determination.
Stefanie D. Krämer, Jean-Claude Gautier, and Philippe Saudemon
Pharmaceutical research, (1998) Berlin: Springer.

1997

Free Fatty Acids Cause pH-Dependent Changes in Drug-Lipid Membrane Interactions Around Physiological pH.
Stefanie D. Krämer, Christina Jakits-Deiser, and Heidi Wunderli-Allenspach
Pharmaceutical research, (1997) Berlin: Springer.

1996

The pH-Dependence in the Partitioning Behaviour of (RS)-[3H]Propranolol Between MDCK Cell Lipid Vesicles and Buffer.
Stefanie D. Krämer, and Heidi Wunderli-Allenspach
Pharmaceutical research, (1996) Berlin: Springer.
 
 
Page URL: http://www.biopharmacy.ethz.ch/publications.html
23.04.2017
© 2017 Eidgenössische Technische Hochschule Zürich